Fortis Healthcare Limited (NSE:FORTIS)
909.95
+1.95 (0.21%)
At close: Jan 14, 2026
Fortis Healthcare Market Cap
Fortis Healthcare has a market cap or net worth of 685.5 billion as of January 14, 2026. Its market cap has increased by 33.12% in one year.
Market Cap
685.50B
Enterprise Value
715.85B
Revenue
84.37B
Ranking
n/a
PE Ratio
67.64
Stock Price
909.95
Market Cap Chart
Since May 9, 2007, Fortis Healthcare's market cap has increased from 22.70B to 685.50B, an increase of 2,919.75%. That is a compound annual growth rate of 19.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 686.97B | 2.94% |
| Dec 31, 2025 | 667.38B | 22.80% |
| Dec 31, 2024 | 543.46B | 71.72% |
| Dec 29, 2023 | 316.48B | 46.52% |
| Dec 30, 2022 | 215.99B | -3.77% |
| Dec 31, 2021 | 224.45B | 91.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.15T |
| Divi's Laboratories | 1.72T |
| Cipla | 1.18T |
| Apollo Hospitals Enterprise | 1.05T |
| Mankind Pharma | 918.20B |
| Zydus Lifesciences | 900.63B |
| Alkem Laboratories | 701.49B |
| Aurobindo Pharma | 681.22B |